Nihon Toseki Igakkai Zasshi
Online ISSN : 1883-082X
Print ISSN : 1340-3451
ISSN-L : 1340-3451
Hypercalcemic crisis due to primary hyperparathyroidism treated by zoledronate in a patient with end-stage renal disease
Hiroyuki Kadoya, Daisuke Ito, Daisuke Mori, Yasuhiro Hirai, Takuma Moriwaki, Jun Matsuda, Hisako Murata, Masanobu Takeji, Atsushi Yamauchi
Author information
JOURNAL FREE ACCESS

2011 Volume 44 Issue 4 Pages 313-318

Details
Abstract
Hypercalcemic crisis is a serious and potentially life-threatening complication of markedly increased serum calcium concentrations most commonly due to primary hyperparathyroidism. We report a case of an 80-year-old man with diabetes mellitus and chronic renal failure, who presented to the emergency department with somnolence, dysarthria and severe hypercalcemia (16.3mg/dL). Despite intensive treatment including elcatonin, alendronate, and intermittent hemodialysis with low calcium dialysate, serum calcium still reached high levels between hemodialysis treatments. The patient was then treated with 4mg of intravenous zoledronate. This treatment greatly reduced the serum calcium level and improved clinical symptoms without major adverse effects. The patient was diagnosed as having primary hyperparathyroidism and was treated by parathyroidectomy. Administration of zoledronate seems to be an effective modality for hypercalcemic crisis in patients with end-stage renal disease.
Content from these authors
© 2011 The Japanese Society for Dialysis Therapy
Previous article Next article
feedback
Top